Best Medpace Alternatives ranked by AI · updated Aug 2026

Medpace is a global contract research organization offering clinical development, central laboratory, biomarker, and regulatory services. It primarily supports biotechnology and pharmaceutical sponsors running studies across therapeutic areas and development phases.

Developer: Medpace Price: N/A 🎯 medpace.com

Clinical Trials pathology oncology central laboratory biomarker testing

Top 6 Medpace alternatives

NeoGenomics Pharma Services

NeoGenomics

NeoGenomics Pharma Services provides central laboratory, anatomic pathology, biomarker, and specialty testing support for biopharmaceutical clinical trials. It is designed for pharmaceutical...

Pros

Strong oncology pathology and biomarker expertise
Offers central lab, specialty testing, and tissue-based services through one provider
Well suited to trials requiring immunohistochemistry, molecular testing, or digital pathology

Cons

More specialized toward oncology than broad full-service CROs
Public pricing and standardized package details are limited
May provide fewer end-to-end clinical operations services than large CROs

N/A

Alternatives to NeoGenomics Pharma... → Visit site

Labcorp

Laboratory Corporation of America Holdings

Labcorp provides clinical laboratory testing, pathology, genetic testing, and drug-development services for patients, providers, employers, and insurers. Its patient services include nationwide...

Pros

Comparable nationwide alternative with a broad routine-testing menu
Strong integration with provider orders and electronic results
Offers consumer-accessible testing for selected services

Cons

Coverage and appointment availability vary by location
Self-pay prices may be unclear until test and billing details are selected
Some tests require a clinician order

Varies by test, location, and insurance

Alternatives to Labcorp → Visit site

Q2 Solutions

IQVIA

Q2 Solutions provides central laboratory, genomic, biomarker, and companion diagnostic services for biopharmaceutical clinical trials. It serves sponsors and CROs globally, with...

Pros

Broader global central-lab network than NeoGenomics
Strong genomics, biomarker, and companion diagnostic capabilities
Integrates laboratory services with IQVIA clinical development infrastructure

Cons

May be less oncology-specialized than NeoGenomics
Large-provider processes can be less flexible for smaller studies
Typically requires a custom commercial proposal

N/A

Alternatives to Q2 Solutions → Visit site

ICON

ICON plc

ICON is a global contract research organization providing clinical development, laboratory, biomarker, and related pharmaceutical services. It serves biotechnology and pharmaceutical sponsors...

Pros

Provides broader end-to-end CRO support than NeoGenomics
Global operational footprint across phases and therapeutic areas
Can coordinate clinical operations, biomarker work, and data services

Cons

Laboratory and pathology work is less central to its identity than at NeoGenomics
May be less nimble for focused oncology testing projects
Broader CRO engagements can increase complexity and cost

N/A

Alternatives to ICON → Visit site

LabConnect

LabConnect provides central laboratory, specialty testing, biomarker, sample management, and laboratory project management services for clinical trials. It works with pharmaceutical, biotechnology,...

Pros

Focused laboratory specialist rather than a broad CRO
Flexible central-lab and specialty-testing support
Provides sample logistics, laboratory project management, and data services

Cons

Less oncology-specific pathology depth than NeoGenomics
Smaller global footprint than the largest CRO-owned laboratories
Does not provide the same breadth of clinical operations as full-service CROs

N/A

Alternatives to LabConnect → Visit site

CellCarta

CellCarta provides biomarker, spatial biology, proteomics, genomics, and immune-monitoring services for biopharmaceutical research and clinical development. It is aimed at sponsors developing...

Pros

Advanced spatial biology, single-cell, and immune-monitoring capabilities
Strong fit for exploratory and translational biomarker programs
Supports complex tissue and blood-based precision medicine studies

Cons

Less focused on routine central laboratory operations than NeoGenomics
May be excessive for standard pathology or basic clinical testing
Advanced assays can require more scientific and operational planning

N/A

Alternatives to CellCarta → Visit site

How good are these alternatives?

Your feedback helps us improve the AI rankings.

✅ Thanks for your feedback!

Know a better alternative? 🙌

Suggest a product and our AI will verify it's a real alternative to Medpace before adding it to the list.